The presence of cardiac pacemakers and defibrillators complicates making end-of-life (EOL) medical decisions. Palliative care/medicine consultation (PCMC) may benefit patients and primary providers, but data are lacking. We retrospectively reviewed 150 charts of patients who underwent device deactivation at our tertiary care center (between November 1, 2008, and September 1, 2012), assessing for PCMC and outcomes. Overall, 42% of patients received a PCMC, and 68% of those PCMCs specifically addressed device deactivation. Median survival following deactivation was 2 days, with 42% of deaths occurring within 1 day of deactivation. There was no difference in survival between the groups. The EOL care for patients with implanted cardiac devices is complex, but PCMC may assist with symptom management and clarification of goals of care for such patients.
BuchEBoyleNGBelottPH. Pacemaker and defibrillator lead extraction. Circulation. 2011;123(11):e378–e380.
2.
GoldsteinNEMehtaDTeitelbaumEBradleyEHMorrisonRS. “It’s like crossing a bridge” complexities preventing physicians from discussing deactivation of implantable defibrillators at the end of life. J Gen Intern Med. 2008;23(suppl 1):2–6.
3.
HemaniSLetiziaM. Providing palliative care in end-stage heart failure. J Hosp Palliat Nurs. 2008;10(2):100–105.
4.
WaterhouseEAhmadF. Do implantable cardioverter defibrillators complicate end-of-life care for those with heart failure?Curr Opin Support Palliat Care. 2011;5(4):307–311.
5.
BuchhalterLCOttenbergALWebsterTLSwetzKMHayesDLMuellerPS. Features and outcomes of patients who underwent cardiac device deactivation. JAMA Intern Med. 2014;174(1):80–85.
6.
SinghBSinghJ. ICD’s near end of life: risk versus benefit: a review. Am J Hosp Palliat Care. 2012;29(6):421–430.
7.
GoldsteinNEMehtaDSiddiquiS. “That’s like an act of suicide” patients’ attitudes toward deactivation of implantable defibrillators. J Gen Intern Med. 2008;23(suppl 1):7–12.
8.
FrommeEKStewartTLJeppesenMTolleSW. Adverse experiences with implantable defibrillators in Oregon hospices. Am J Hosp Palliat Care. 2011;28(5):304–309.
9.
LampertRHayesDLAnnasGJ. HRS expert consensus statement on the management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm. 2010;7(7):1008–1026.
10.
PadelettiLArnarDOBoncinelliL. EHRA expert consensus statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy. Europace. 2010;12(10):1480–1489. Erratum in: Europace. 2011;13(4):599.
11.
MatlockDDNowelsCTBekelmanDB. Patient perspectives on decision making in heart failure. J Card Fail. 2010;16(10):823–826.
12.
MatlockDDNowelsCTMasoudiFA. Patient and cardiologist perceptions on decision making for implantable cardioverter-defibrillators: a qualitative study. Pacing Clin Electrophysiol. 2011;34(12):1634–1644.
13.
GoldsteinNELampertRBradleyELynnJKrumholzHM. Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med. 2004;141(11):835–838.
14.
MorrisonLJCalvinAONoraHPorter StoreyCJr. Managing cardiac devices near the end of life: a survey of hospice and palliative care providers. Am J Hosp Palliat Care. 2010;27(8):545–551.
15.
LewisWRLuebkeDLJohnsonNJHarringtonMDCostantiniOAulisioMP. Withdrawing implantable defibrillator shock therapy in terminally ill patients. Am J Med. 2006;119(10):892–896.
16.
ClarkAMJaarsmaTStrachanP. Effective communication and ethical consent in decisions related to ICDs. Nat Rev Cardiol. 2011;8(12):694–705.
17.
QuillTEAbernethyAP. Generalist plus specialist palliative care: creating a more sustainable model. N Engl J Med. 2013;368(13):1173–1175.
18.
MatlockDDMandrolaJM. The antidote for unprepared patients: a caring clinician. JAMA Intern Med. 2014;174(1):86–87.
19.
GoldsteinNCarlsonMLivoteEKutnerJS. Brief communication: management of implantable cardioverter-defibrillators in hospice: a nationwide survey. Ann Intern Med. 2010;152(5):296–299.
20.
KelleyASMehtaSSReidMC. Management of patients with ICDs at the end of life (EOL): a qualitative study. Am J Hosp Palliat Care. 2008-2009;25(6):440–446.
21.
ZhanCBaineWBSedrakyanASteinerC. Cardiac device implantation in the United States from 1997 through 2004: a population-based analysis. J Gen Intern Med. 2008;23(suppl 1):13–19.
22.
LinGMeverdenRAHodgeDOUslanDZHayesDLBradyPA. Age and gender trends in implantable cardioverter defibrillator utilization: a population based study. J Interv Card Electrophysiol. 2008;22(1):65–70.
23.
UslanDZTleyjehIMBaddourLM. Temporal trends in permanent pacemaker implantation: a population-based study. Am Heart J. 2008;155(5):896–903.
24.
MuellerPSJenkinsSMBramstedtKAHayesDL. Deactivating implanted cardiac devices in terminally ill patients: practices and attitudes. Pacing Clin Electrophysiol. 2008;31(5):560–568.
25.
von GuntenCFWeissmanDE. Consultation etiquette in palliative care #266. J Palliat Med. 2013;16(5):578–579.
26.
SilveiraMJKimSYLangaKM. Advance directives and outcomes of surrogate decision making before death. N Engl J Med. 2010;362(13):1211–1218.
27.
MalloyTRWigtonRSMeeskeJTapeTG. The influence of treatment descriptions on advance medical directive decisions. J Am Geriatr Soc. 1992;40(12):1255–1260.
28.
HeerenOMenonASRaskinARuskinP. Religion and end of life treatment preferences among geriatric patients. Int J Geriatr Psychiatry. 2001;16(2):203–208.
29.
BurdetteAMHillTDMoultonBE. Religion and attitudes toward physician-assisted suicide and terminal palliative care. J Sci Study Relig. 2005;44(1):79–93.
30.
ButlerKPuriS. Deathbed shock: causes and cures. JAMA Intern Med. 2014;174(1):88–89.
31.
HillLMcIlfatrickSTaylorBDixonLHarbinsonMFitzsimonsD. Patients’ perception of implantable cardioverter defibrillator deactivation at the end of life. Palliat Med. 2015;29(4):310–323.
32.
PasalicDTajouriTHOttenbergALMuellerPS. The prevalence and contents of advance directives in patients with pacemakers. Pacing Clin Electrophysiol. 2014;37(4):473–480.
33.
TajouriTHOttenbergALHayesDLMuellerPS. The use of advance directives among patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2012;35(5):567–573.
34.
TemelJSGreerJAMuzikanskyA. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733–742.
